ConductScience.org, home

Trial · NCT01228994

Baclofen for Smoking Cessation in a Non-Psychiatric Population

NCT01228994, Phase 2, Terminated, Centre for Addiction and Mental Health

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Baclofen for Smoking Cessation in a Non-Psychiatric Population. Trials, record NCT01228994. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01228994

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Baclofen for Smoking Cessation in a Non-Psychiatric Population
NCT number
NCT01228994
Status
Terminated
Phases
Phase 2
Enrollment
6 participants, actual
Lead sponsor
Centre for Addiction and Mental Health
Conditions
Nicotine Dependence
Interventions
Baclofen 30 mg/day, placebo pill, Baclofen 60 mg/day
First posted
2010-10-27
Last updated
2013-09-12

Source ClinicalTrials.gov

Registered outcomes5

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimarySmoking abstinence for 7 days at end of treatmentend of treatment week 10At end of treatment subjects will report smoking consumption for past 7 days. Subject are considered abstinent based on self report and verfied by CO level (\<10 PPM)
PrimaryAbstinent rate: last four weeks of triallast 4 weeks of trial (week 7 to 10)subjects report cigarette consumption during the last 4 weeks of the clinical trial. abstinence rates are verifed by CO \< 10 PPM
Primaryabstinence rate: for past 7 days at 6 month followup6 month followup
Subject are asked to attend a 6 month followup. At this time subjects will be asked to report their cigarette consumption for the past 7 days. abstinence is based on this self report and verified by CO levels \<10 PPM
SecondaryTiffany Questionnaire of Smoking Urgesscreen, week 1,4,7,10, abd 6 month followuptobacco craving is monitored at different time points of the trial
SecondaryMinnesota Nicotine Withdrawal ScaleScreen, week 1,4,7,10 and 6 month followup
This scale assesses symptoms of tobacco withdrawal including nicotine craving, irritability, anziety, difficulty conentrating, restlessness, headaches, fatigue, increased appetite, weight gain, and insomnia.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT01228994

GET https://conductscience.org/api/trials/v1/NCT01228994/registered